The company aims to wind down the clinical trials unit in phases, with a full exit expected by Dec. 31, 2024.
“We’ll work with our trial sponsors to ensure a smooth transition, as well as continuity of care and minimal disruption for patients,” a spokesperson for CVS told Becker’s. “In parallel, we’re working to support impacted colleagues, and will provide career transition support for those unable to find another role within CVS Health.”
CVS launched the unit in May 2021 to broaden access to clinical trials and create a better experience for participants to improve retention rates. It is not yet clear whether CVS’ clinical trials business has been financially successful.
Walgreens and Walmart also entered the clinical trials sector last year, while Kroger launched a clinical trial site network in January.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.